Biotechnology | Disease | FDA | Therapeutics
Omeros received FDA Approval of Omidria
On Jun. 2, 2014, Omeros received U.S. Food and Drug Administration (FDA) approval of Omidria for use in…
Stanford Medicine researchers found that a gene variant puts women at higher risk of Alzheimer’s than it does men
On Apr. 14, 2014, Stanford Medicine researchers announced a study that found a gene variant puts women at…
DNA was isolated from the deadly 1849 cholera outbreak in Philadelphia
On Jan. 9, 2014, DNA was isolated from a 165-year-old intestine of a cholera victim from Philadelphia – …
The first-ever living, three-dimensional human arrhythmic heart tissue is bioengineered at the University of Toronto
On Nov. 20, 2013, researchers at the University of Toronto’s Institute of Biomaterials & Biomedical Engineering and the…
Largest international study of Alzheimer’s genes was published
On Oct. 28, 2013, Columbia University Medical Center announced publication of a Meta-analysis of 74,046 individuals that identified…
A second $10 million gift from Jerre and Mary Joy Stead advances children’s medicine at the University of Iowa
On Oct. 24, 2013, the University of Iowa (IA) announced a second $10 million gift commitment from Jerre…
Kern Family donated $100 million to Mayo Clinic to transform health care
On Oct. 23, 2013, the Mayo Clinic announced that Robert and Patricia Kern have given $100 million to…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
UNMC named new cancer center the Fred & Pamela Buffett Cancer Center
On Jun. 7, 2013, the University of Nebraska Board of Regents approved renaming the UNMC Eppley Cancer Center…
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Biotechnology | COVID-19 | Diagnostics | Disease | Genomics | Therapeutics
The Human Genome Project was completed
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had approved Genentech’s licensed ado-trastuzumab…
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the four subcategories of possible autistic disorder
In 2013, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders merged three of the…
GDF-11 was discovered to reverse cardiac hypertrophy
In 2013, Harvard Medical School researchers announced they had discovered that GDF-11 reverses cardiac hypertrophy, or thickening of…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
A new phlebovirus (Heartland virus) associated with severe febrile illness in Missouri published
On Aug. 30, 2012, a new phlebovirus, discovered in northwestern Missouri by Dr. Scott Folk of Heartland Regional…
The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
Biotechnology | Disease | FDA | Vaccine
FDA approved HibMenCY vaccine for infants
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
The U.S. Senate declared May 16, 2012 as Hereditary Angioedema Awareness Day (HAE)
ON May 16, 2012, the U.S. Senate unanimously passed a resolution (S. Res. 286) recognizing May 16, 2012,…
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
Hologic acquired Gen-Probe for $37 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
University of Washington Medical Center becomes first in PNW to discharge Total Artificial Heart patient
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 8, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
Middle East Respiratory Syndrome (MERS) was first reported in Saudi Arabia
In 2012, Middle East Respiratory Syndrome (MERS), a viral respiratory illness, was first reported in Saudi Arabia in…
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…